Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

[1] Sugarbaker PH(2012)Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13 e362-e369

[2] Ryan DP(2022)In patients undergoing CRS/HIPEC for colorectal adenocarcinoma with peritoneal metastases, presence of ascites on computed tomography imaging is not a prognostic marker for survival Ann Surg Oncol 29 5256-5262

[3] Said I(1999)Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features World J Surg 23 23-29

[4] Ubink I(2004)Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer Eur J Surg Oncol 30 864-868

[5] Ewalds RSG(2020)The local inflammatory response in colorectal cancer - type, location or density? A systematic review and meta-analysis Cancer Treat Rev 83 101949-464

[6] Arkesteijn JGT(2018)Staging the tumor and staging the host: a two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer Am J Surg 216 458-70

[7] Verheul HMW(2011)Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer Crit Rev Clin Lab Sci. 48 155-706

[8] de Wilt JHW(2018)Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors PLoS One. 13 e0202555-2398

[9] Dekker HM(2021)Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia Hematol Oncol 39 697-1338

[10] Bremers AJA(2010)Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg 34 2393-886

[1] Sugarbaker PH(2012)Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13 e362-e369

[2] Ryan DP(2022)In patients undergoing CRS/HIPEC for colorectal adenocarcinoma with peritoneal metastases, presence of ascites on computed tomography imaging is not a prognostic marker for survival Ann Surg Oncol 29 5256-5262

[3] Said I(1999)Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features World J Surg 23 23-29

[4] Ubink I(2004)Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer Eur J Surg Oncol 30 864-868

[5] Ewalds RSG(2020)The local inflammatory response in colorectal cancer - type, location or density? A systematic review and meta-analysis Cancer Treat Rev 83 101949-464

[6] Arkesteijn JGT(2018)Staging the tumor and staging the host: a two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer Am J Surg 216 458-70

[7] Verheul HMW(2011)Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer Crit Rev Clin Lab Sci. 48 155-706

[8] de Wilt JHW(2018)Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors PLoS One. 13 e0202555-2398

[9] Dekker HM(2021)Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia Hematol Oncol 39 697-1338

[10] Bremers AJA(2010)Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg 34 2393-886